ℹ️
🇬🇧
Search
Search for people relevant for "miR-92a"
miR-92a
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Heidi Móciková Ph.D.
Academic staff at Third Faculty of Medicine
98 publications
Publications
publication
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study
2024 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Faculty of Pharmacy in Hradec Králové
publication
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2023 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
2023 |
Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic
2023 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Cognitive impairment associated with Hodgkin's lymphoma and chemotherapy
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Akalabrutinib v léčbě chronické lymfocytární leukemie s autoimunitní hemolytickou anemií
2023 |
Third Faculty of Medicine
publication
84. Monitoring and care after curative treatment for lymphomas
2023 |
Third Faculty of Medicine
publication
Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
2022 |
First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)
2022 |
First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world
2022 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
Load more publications (88)
Loading network view...